Tag Archives: Drug

Novartis snags blockbuster OK for secondary progressive multiple sclerosis drug Mayzent

Novartis officially has an approval for Mayzent to treat patients with secondary progressive multiple sclerosis. The next challenge? Getting doctors to diagnose it. The FDA green-lighted the product Tuesday, making it the first-ever oral drug for SPMS and the first new treatment specifically approved for the condition more than 15 years. Regulators based their decision… Read More »